Scientific article
French

Polypharmacie et medicaments inappropriés chez les patients âgés multimorbides - Ce que l’étude OPERAM nous apprend et va nous apprendre

Other title[Polypharmacy and inappropriate medications in multimorbid elderly patients - What OPERAM taught us and will teach us]
Published inRevue médicale suisse, vol. 18, no. 772, p. 427-432
Publication date2022-03-09
Abstract

Polypharmacy and inappropriate medication use are very common in multimorbid older patients. This population has unfortunately been excluded from most large, randomized studies. In a recent multicenter randomized study (OPERAM), we included over 2000 multimorbid patients. We found that 86% of the patients aged 70 years and more had inappropriate medications and that these medications could be discontinued without negative impact on the health of these patients. This cohort of multimorbid patients will be followed for 10 years to evaluate their prognosis, life expectancy, treatments and quality of life, with numerous projects to better understand the inappropriate prescribing of individual drugs and their consequences on the health of this population.

Keywords
  • Aged
  • Aged, 80 and over
  • Humans
  • Inappropriate Prescribing
  • Multicenter Studies as Topic
  • Multimorbidity
  • Polypharmacy
  • Potentially Inappropriate Medication List
  • Quality of Life
  • Randomized Controlled Trials as Topic
Citation (ISO format)
BRETAGNE, Lisa et al. Polypharmacie et medicaments inappropriés chez les patients âgés multimorbides - Ce que l’étude OPERAM nous apprend et va nous apprendre. In: Revue médicale suisse, 2022, vol. 18, n° 772, p. 427–432. doi: 10.53738/REVMED.2022.18.772.427
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1660-9379
145views
0downloads

Technical informations

Creation01/04/2022 12:04:00
First validation01/04/2022 12:04:00
Update time16/03/2023 06:40:46
Status update16/03/2023 06:40:44
Last indexation01/10/2024 21:24:48
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack